MedTrace Logo

International Randomized Comparison Between DES Limus Carbostent and Taxus DES in the Treatment of De-novo Coronary Lesions

NCT01373502 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 323

Last updated 2018-04-30

No results posted yet for this study

Summary

The purpose of this study is to demonstrate non-inferiority in terms of safety and efficacy of DES Limus Carbostent compared to the Taxus Liberté in treating de-novo atherosclerotic lesions in native coronary arteries.

Conditions

  • Stable Angina
  • Unstable Angina
  • Documented Silent Ischemia

Interventions

DEVICE

DES Limus Carbostent

DES Limus Carbostent Carbofilm Coated Coronary Stent

DEVICE

Taxus Liberté Stent

Taxus Liberté Coronary Stent

Sponsors & Collaborators

  • CID - Carbostent & Implantable Devices

    lead INDUSTRY

Principal Investigators

  • Didier Carrié, Prof · Hôpital de Rangueil, Toulouse Cedex 4 - France

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2011-04-30
Completion
2015-10-31

Countries

  • Belgium
  • France
  • Germany
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01373502 on ClinicalTrials.gov